| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | Jul 31, 2025 | Cardiff Oncology, Inc. | Director | Buy | 97.5 | +290,000 | 12.15% | ✗ | $710.5K |
| Dec 11, 2024 | Dec 12, 2024 | Cardiff Oncology, Inc. | Director | Buy | 97.5 | +361,615 | 20.72% | ✗ | $940.2K |
| Mar 6, 2024 | Mar 8, 2024 | Pacira BioSciences, Inc. | Director | Sell | 17.5 | -119,323 | -84.36% | ✗ | $3.7M |
| Dec 19, 2023 | Dec 19, 2023 | Cardiff Oncology, Inc. | Director | Buy | 83.8 | +30,000 | 4.49% | ✗ | $41.1K |
| Nov 10, 2023 | Nov 14, 2023 | Cardiff Oncology, Inc. | Director | Buy | 83.8 | +22,950 | 3.56% | ✗ | $22.5K |
| May 11, 2023 | May 15, 2023 | Pacira BioSciences, Inc. | Director | Sell | 22.5 | -5,015 | -3.47% | ✗ | $209.5K |
| Sep 15, 2022 | Sep 19, 2022 | Cardiff Oncology, Inc. | Director | Buy | 97.5 | +150,000 | 30.31% | ✗ | $256.5K |
| Feb 28, 2022 | Mar 1, 2022 | Pacira BioSciences, Inc. | Director | Sell | 17.5 | -30,000 | -10.38% | ✗ | $2M |
| Sep 21, 2021 | Sep 22, 2021 | Cardiff Oncology, Inc. | Director | Buy | 90.0 | +30,000 | 6.45% | ✗ | $202.5K |
| Mar 23, 2021 | Mar 24, 2021 | Cardiff Oncology, Inc. | Director | Buy | 82.5 | +10,000 | 2.20% | ✗ | $102.3K |
| Mar 18, 2021 | Mar 19, 2021 | Cardiff Oncology, Inc. | Director | Buy | 68.8 | +3,000 | 0.66% | ✗ | $31.7K |
| Mar 4, 2021 | Mar 4, 2021 | Cardiff Oncology, Inc. | Director | Buy | 61.3 | +1,500 | 0.33% | ✗ | $13.9K |
| Sep 16, 2020 | Sep 17, 2020 | Cardiff Oncology, Inc. | Director | Buy | 68.8 | +2,550 | 0.57% | ✗ | $14.5K |
| May 11, 2020 | May 13, 2020 | Cardiff Oncology, Inc. | Director | Buy | 97.5 | +447,761 | 100.00% | ✗ | $600K |
| Nov 19, 2018 | Nov 21, 2018 | Pacira BioSciences, Inc. | Director | Buy | 95.0 | +4,500 | 15.89% | ✗ | $207.8K |
| Nov 7, 2018 | Nov 9, 2018 | Pacira BioSciences, Inc. | Director | Buy | 95.0 | +4,000 | 16.45% | ✗ | $205.2K |
| May 8, 2018 | May 10, 2018 | RESMED INC | Director | Sell | 17.5 | -28,403 | -22.02% | ✗ | $2.8M |
| Mar 13, 2015 | Mar 17, 2015 | Pacira BioSciences, Inc. | Director | Buy | 90.0 | +1,000 | 5.65% | ✗ | $93.8K |